95 related articles for article (PubMed ID: 33488711)
1. Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis.
Xu Z; Feng J; Weng Y; Jin Y; Peng M
J Oncol; 2021; 2021():6631643. PubMed ID: 33488711
[TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis.
Liu SJ; Yan LJ; Wang HC; Ding ZN; Liu H; Zhang X; Pan GQ; Han CL; Tian BW; Yang XR; Tan SY; Dong ZR; Wang DX; Yan YC; Li T
Oncologist; 2024 Jun; ():. PubMed ID: 38940446
[TBL] [Abstract][Full Text] [Related]
3. Effect of Sequence of Radiotherapy Combined With Immunotherapy on the Incidence of Pneumonitis in Patients With Lung Cancer: A Systematic Review and Network Meta-Analysis.
Mi S; Liang N; Zhang Y; Zhang Y; Wang F; Qiao L; Chen F; Hu P; Zhang J
Clin Lung Cancer; 2024 Jan; 25(1):18-28.e3. PubMed ID: 37612176
[TBL] [Abstract][Full Text] [Related]
4. Intracranial radiotherapy with or without immune checkpoint inhibition for brain metastases: a systematic review and meta-analysis.
He Q; Zhang C; Tang S; Li J; Ren Q
Transl Cancer Res; 2020 Oct; 9(10):5909-5924. PubMed ID: 35117204
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study.
Boyer M; Şendur MAN; Rodríguez-Abreu D; Park K; Lee DH; Çiçin I; Yumuk PF; Orlandi FJ; Leal TA; Molinier O; Soparattanapaisarn N; Langleben A; Califano R; Medgyasszay B; Hsia TC; Otterson GA; Xu L; Piperdi B; Samkari A; Reck M;
J Clin Oncol; 2021 Jul; 39(21):2327-2338. PubMed ID: 33513313
[TBL] [Abstract][Full Text] [Related]
6. Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Heo JY; Yoo SH; Suh KJ; Kim SH; Kim YJ; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS; Lee JS
Sci Rep; 2021 Jan; 11(1):2514. PubMed ID: 33510255
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined With Chemotherapy in First-line Treatment of Small Cell Lung Cancer.
Wu J; Zhang A; Li L; Liu S; Yang F; Yang R
Clin Ther; 2021 Mar; 43(3):582-593.e2. PubMed ID: 33509647
[TBL] [Abstract][Full Text] [Related]
8. The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules.
Keisari Y; Kelson I
Cells; 2021 Jan; 10(2):. PubMed ID: 33503958
[TBL] [Abstract][Full Text] [Related]
9. A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player.
Zhou Y; Yu F; Zhao Y; Zeng Y; Yang X; Chu L; Chu X; Li Y; Zou L; Guo T; Zhu Z; Ni J
Transl Lung Cancer Res; 2020 Dec; 9(6):2479-2493. PubMed ID: 33489808
[TBL] [Abstract][Full Text] [Related]
10. Shared Decision Making in Early-Stage Non-small Cell Lung Cancer: A Systematic Review.
Dalmia S; Boele F; Absolom K; Brunelli A; Franks K; Bekker HL; Pompili C
Ann Thorac Surg; 2022 Aug; 114(2):581-590. PubMed ID: 33581150
[TBL] [Abstract][Full Text] [Related]
11. Induction treatment in patients with stage III non-small cell lung cancer.
Palmero R; Vilariño N; Navarro-Martín A; Nadal E
Transl Lung Cancer Res; 2021 Jan; 10(1):539-554. PubMed ID: 33569335
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer.
Alcibar OL; Nadal E; Romero Palomar I; Navarro-Martin A
Transl Lung Cancer Res; 2021 Jan; 10(1):529-538. PubMed ID: 33569334
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of residential radon and lung cancer in never-smokers.
Cheng ES; Egger S; Hughes S; Weber M; Steinberg J; Rahman B; Worth H; Ruano-Ravina A; Rawstorne P; Yu XQ
Eur Respir Rev; 2021 Mar; 30(159):. PubMed ID: 33536262
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer.
Kartolo A; Holstead R; Hopman W; Young L; Baetz T
J Oncol Pharm Pract; 2022 Jan; 28(1):87-95. PubMed ID: 33509058
[TBL] [Abstract][Full Text] [Related]
15. Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.
Gauvin C; Krishnan V; Kaci I; Tran-Thanh D; Bédard K; Albadine R; Leduc C; Gaboury L; Blais N; Tehfe M; Routy B; Florescu M
Curr Oncol; 2021 Jan; 28(1):593-605. PubMed ID: 33498159
[TBL] [Abstract][Full Text] [Related]
16. Factors Modifying the Associations of Single or Combination Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Inhibitor Therapies With Survival Outcomes in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Sati N; Boyne DJ; Cheung WY; Cash SB; Arora P
JAMA Netw Open; 2021 Jan; 4(1):e2034201. PubMed ID: 33496794
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota influence tumor development and Alter interactions with the human immune system.
Ge Y; Wang X; Guo Y; Yan J; Abuduwaili A; Aximujiang K; Yan J; Wu M
J Exp Clin Cancer Res; 2021 Jan; 40(1):42. PubMed ID: 33494784
[TBL] [Abstract][Full Text] [Related]
18. Surgery in Small-Cell Lung Cancer.
Martucci N; Morabito A; La Rocca A; De Luca G; De Cecio R; Botti G; Totaro G; Muto P; Picone C; Esposito G; Normanno N; La Manna C
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494285
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Low-Dose Radiotherapy Combined with Immune Checkpoint Inhibition in Metastatic Solid Tumors.
Li D; Zhu W; Zhou J; Peng M; Geng Q; Pu X; Wang M; Jiang H
Onco Targets Ther; 2021; 14():773-783. PubMed ID: 33568917
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy may exacerbated anti-programmed cell death 1 treatment induced vitiligo: A case report.
Chen C; Chang Q; Wang B; Wang Y; Zhang Z; Wang X
Skin Health Dis; 2024 Feb; 4(1):e287. PubMed ID: 38312255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
